IL1R1 and Parkinson disease: Interestingly, LPS treatment in mice lacking IL-1R1 did not increase the expression of α-synuclein or the downstream consequences, highlighting the key role of IL-1R1 in the propagation of α-synuclein pathology from the olfactory bulb to the SN, supporting the possible involvement of this pro-inflammatory receptor in PD progression [96].